What was Gabather AB’s price range in the past 12 months?
Gabather AB lowest stock price was kr0.03 and its highest was kr0.21 in the past 12 months.
What is Gabather AB’s market cap?
Gabather AB’s market cap is kr7.56M.
When is Gabather AB’s upcoming earnings report date?
Gabather AB’s upcoming earnings report date is Feb 26, 2026 which is in 71 days.
How were Gabather AB’s earnings last quarter?
Gabather AB released its earnings results on Nov 27, 2025. The company reported kr0 earnings per share for the quarter, the consensus estimate of kr0 by kr0.
How many shares outstanding does Gabather AB have?
Gabather AB has 236,204,880 shares outstanding.
What happened to Gabather AB’s price movement after its last earnings report?
Gabather AB reported an EPS of kr0 in its last earnings report, expectations of kr0. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Gabather AB?
Currently, no hedge funds are holding shares in SE:GABA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Gabather AB
Gabather AB (GABA) is a biotechnology company based in Sweden that focuses on the development of innovative pharmaceutical therapies targeting central nervous system (CNS) disorders. The company is dedicated to creating novel treatments for psychiatric and neurological conditions by leveraging its proprietary research and development capabilities to address unmet medical needs.